Intranet
Careers
Contact Us
Directory
Sitemap
Salk
About
Leadership
History of Salk
Architecture Tour Information
Salk in the Community
Society of Research Fellows
Careers
Contact Us/Directions
Scientists & Research
Scientists
Research Areas
Research Centers
Laboratories
Scientific Cores
Technology Transfer
News & Media
Salk News
Our Magazine
InsideSalk
Publications
Salk In The Media
Salk Videos
Contact Us
Events
Science Events
Upcoming Salk Donor Events
Salk Events Blog
Support Salk
Giving Options
Your Gift at Work
Donors Why We Give
The Campaign for Salk
Contact Us
Donate
Technologies Available for Licensing
Home >
Office of Technology Development >
HOME
SEARCH
RSS FEED
Search Results - o'shea
4
Results
Sort By:
Published Date
Title
ID
Descending
Ascending
Anti-Cancer Adenoviruses
Rapid Generation of Customized Tumor-Selective Oncolytic Adenoviruses Allows for the efficient optimization of viruses for use in oncolytic viral therapies. INVENTION: The goal of oncolytic viral therapy is to specifically infect and kill tumor cells without causing damage to normal cells. Although adenovirus is one of the most commonly used ...
Published: 4/9/2014
|
Inventor(s):
Keywords(s):
Adenovirus
,
Cancer Therapeutics
,
Cancer Vaccines
,
Oncology
,
Oncolytic Therapy
,
O'Shea
,
Personalized Medicine
,
Proliferative disorders
,
Synthetic Biology
,
Tumors
,
Vaccine
,
Viral Vectors
,
Virus
Category(s):
Oncology
Oncolytic Viral Cancer Immunotherapy
Oncolytic Viral Cancer Immunotherapy Modular construction of targeted, systemically delivered oncolytic adenovirus for immunotherapy of cancer. INVENTION: Oncolytic viruses are exquisite tumor-selective, multi-mechanistic antitumor agents that can kill cancer cells, not just through direct oncolysis, but also via immunogenic cell death. These ...
Published: 4/9/2014
|
Inventor(s):
Keywords(s):
Adenovirus
,
Cancer Therapeutics
,
Cancer Vaccines
,
Immunotherapies
,
Malignancy
,
Oncology
,
Oncolytic Therapy
,
O'Shea
,
Targeted Therapies
,
Viral Vectors
Category(s):
Oncology
Adenoviral Tumor Diagnostics
Adenoviral Tumor Diagnostics Diagnostic viral reporters to define the malignant phenotype of tumors, and functionally determine their ability to respond to different therapies. INVENTION: Genome sequencing has accelerated our understanding of how molecular alterations determine a tumor's response to targeted drugs, ultimately leading to the ...
Published: 4/9/2014
|
Inventor(s):
Keywords(s):
Adenovirus
,
Cancer Diagnostics
,
Circulating Tumor Cells
,
Diagnostic
,
DNA Virus
,
Oncology
,
O'Shea
,
Personalized Medicine
,
Synthetic Biology
,
Tumors
,
Viral Reporters
,
Virus
Category(s):
Diagnostics/Biomarkers
,
Oncology
Adenoviral Assembly Method
Modular Adenovirus Assembly Platform Custom, rapid and systematic assembly of recombinant adenoviral genomes from modular parts. INVENTION: Although adenoviral vectors are regularly used for the delivery of exogenous DNA to mammalian cells for basic science research, vaccines and gene therapy, the potential of adenoviral vectors in several ap...
Published: 4/9/2014
|
Inventor(s):
Keywords(s):
Adenovirus
,
Cancer Diagnostics
,
Cancer Therapeutics
,
Cancer Vaccines
,
DNA Virus
,
Gene Delivery
,
Gene Expression
,
Gene Therapy
,
Immunotherapies
,
Oncology
,
Oncolytic Therapy
,
O'Shea
,
Targeted Therapies
,
Vaccine
,
Viral Vectors
,
Virus
Category(s):
Diagnostics/Biomarkers
,
Drug Discovery
,
Oncology
,
Regenerative Medicine
,
Research Reagents
,
Vaccines
Home
|
Search
|
RSS
© 2018. All Rights Reserved. Powered by
Inteum
